Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Clin Cancer Res 2014
Solubility: DMSO : 100 mg/mL (246
Glut1 deficiency syndrome and erythrocyte glucose uptake assay
InChi: InChI=1S/C21H26NO3
CAS Number: 1271738-59-0
Betrixaban 40551 Clin Cancer Res 2014Betrixaban, also known as PRT054021, MK 4448; PRT 021; PRT 054021; MLN 1021, is a potent, orally active and highly selective factor Xa inhibitor undergone human clinical trials for prevention of embolism after knee surgery, and prevention of stroke following atrial fibrillation. Betrixaban is currently being studied in a human clinical trial for extended duration thromboprophylaxis to prevent venous thromboembolism in acute medically ill patients.
US$ 200.00
US$ 370.00
US$ 1900.00
US$ 180.00
US$ 200.00
US$ 249.00
US$ 160.00
US$ 325.00
US$ 184.00
US$ 1250.00
US$ 1700.00
US$ 325.00
US$ 1225.00